a) Cartoon depicting the FoxO1 network involved in the regulation
of cell cycle progression and cellular senescence: FoxO1 arrests the cell cycle by
repressing activators (cyclinD1, cyclinD2) and inducing inhibitors (cdkn1a/p21,
cdkn1b/p27, cdkn2b/p15Ink4b, cdkn1c/p57) [PMID: 10102273; PMID: 17873901]. cdkn1a/p21
and cdkn2b/p15Ink4b activation, a sign of cellular senescence [PMID: 17667954], is
regulated by FoxO1 through direct interaction with Skp2 protein. In turn, Skp2 blocks
FoxO1 and, together with CKS1b, CDK1 and CDK2, triggers the direct degradation of
cdkn1a/p21 and cdkn1b/p27, thus promoting proliferation [PMID: 15668399]. FoxO proteins
are inhibited mainly through PI3K/AKT-mediated phosphorylation [PMID: 10102273, PMID:
12621150, PMID: 21708191, PMID: 10217147, PMID: 17604717]: PDK1, the master kinase of
the pathway, stimulates cell proliferation and survival by directly activating AKT,
which phosphorylates (inhibits) the FoxOs [PMID: 10698680, PMID: 19635472].
PI3K/AKT/FoxO1 circuit requires active TGFβ/SMAD signaling [PMID: 24238962, PMID:
15084259] in order to co-regulate cdkn1a/p21-dependent cell senescence. Active
TGFβ signaling downregulates the BMP pathway downstream effectors ID1 and ID2,
known to promote dedifferentiation and proliferation during embryogenesis and cancer
progression, probably through cdkn2b/p15Ink4b regulation [PMID: 11840321, PMID:
16034366]. b) β-cell ablation in adults triggers FoxO1 upregulation
and the subsequent cell cycle arrest in δ-cells.